Liver Cancer pp 463-483 | Cite as

Hilar Cholangiocarcinoma: Photodynamic Therapy and Stenting

  • Marcus Wiedmann
  • Joachim Mössner
  • Helmut Witzigmann
Part of the Methods of Cancer Diagnosis, Therapy and Prognosis book series (HAYAT, volume 5)

Carcinomas of the biliary tree are rare tumors of the gastrointestinal tract with rising inci dence during the last years. Endoscopic therapy plays a central role in the preopera-tive and palliative treatment of extrahepatic cholangiocarcinoma (CC). In obstructive jaundice, biliary drainage may cause only few complications and relieves symptoms reliably. It can prevent further complica tions and is indispensable in the treatment of cholangitis. The principal drawbacks of biliary stents are stent occlusion and cholangitis. Prophylactic application of antibiotics and/or ursodeoxycholic acid has not been shown to be effective. Technical details concerning material, number and location of stents await further clarification. There are no prospective randomized tri als investigating the effect of preoperative biliary drainage on morbidity and mortality in jaundized patients before liver resection. Palliative surgical cholangio-jejunostomy with the bile duct of liver segment III for Klatskin-tumors is rarely performed due to the high success rate of stent therapy. Self-expandable metal stents (SEMS) are a safe, efficacious and less invasive treatment option for palliation of duodenal obstruc tion in biliary tract cancer. Technical com-plications can be managed endoscopically and the bile duct remains accessible for endoluminal treatment. Palliative photo-dynamic therapy (PDT) for non-resectable hilar CC is effective in prolonging survival, improving biliary drainage and quality of life, and represents a promising adjunct to palliative therapy. Early referral for PDT may provide maximum survival benefit. In contrast, neoadjuvant and adjuvant PDT for hilar CC is a new approach that needs further evaluation.


Bile Duct Photodynamic Therapy Biliary Drainage Biliary Tract Cancer Hilar Cholangiocarcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Berr, F., Tannapfel, A., Lamesch, P., Pahernik, S., Wiedmann, M., Halm, U., Goetz, A. E., Mossner, J., and Hauss, J., 2000a. Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma. J. Hepatol. 32: 352–357.CrossRefGoogle Scholar
  2. Berr, F., Wiedmann, M., Tannapfel, A., Halm, U., Kohlhaw, K. R., Schmidt, F., Wittekind, C., Hauss, J., and Mossner, J., 2000b. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 31: 291–2988.CrossRefGoogle Scholar
  3. Burmester, E., Niehaus, J., Leineweber, T., and Huetteroth, T., 2003. EUS-cholangio-drainage of the bile duct: report of 4 cases. Gastrointest. Endosc. 57: 246–251.PubMedCrossRefGoogle Scholar
  4. Chang, W. H., Kortan, P., and Haber, G. B., 1998. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest. Endosc. 47: 354–362.PubMedCrossRefGoogle Scholar
  5. Cherqui, D., Benoist, S., Malassagne, B., Humeres, R., Rodriguez, V., and Fagniez, P. L., 2000. Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch. Surg. 135: 302–308.PubMedCrossRefGoogle Scholar
  6. de Groen, P. C., Gores, G. J., LaRusso, N. F., Gunderson, L. L., and Nagorney, D. M., 1999. Biliary tract cancers. N. Engl. J. Med. 341: 1368–1378.PubMedCrossRefGoogle Scholar
  7. De Palma, G. D., Galloro, G., Siciliano, S., Iovino, P., and Catanzano, C., 2001. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and control led study. Gastrointest. Endosc. 53: 547–553.PubMedCrossRefGoogle Scholar
  8. Deviere, J., Baize, M., de Toeuf, J., and Cremer, M., 1988. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest. Endosc. 34: 95–101.PubMedCrossRefGoogle Scholar
  9. Doctor, N., Dick, R., Rai, R., Dafnios, N., Salamat, A., Whiteway, H., Dooley, J., and Davidson, B. R., 1999. Results of percutaneous plastic stents for malignant distal biliary obstruction following failed endoscopic stent insertion and comparison with current literature on expandable metal lic stents. Eur. J. Gastroenterol. Hepatol. 11: 775–780.PubMedCrossRefGoogle Scholar
  10. Ducreux, M., Liguory, C., Lefebvre, J. F., Ink, O., Choury, A., Fritsch, J., Bonnel, D., Derhy, S., and Etienne, J. P., 1992. Management of malig nant hilar biliary obstruction by endoscopy. Results and prognostic factors. Dig. Dis. Sci. 37: 778–783.PubMedCrossRefGoogle Scholar
  11. Dumoulin, F. L., Gerhardt, T., Fuchs, S., Scheurlen, C., Neubrand, M., Layer, G., and Sauerbruch, T., 2003. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonre-sectable hilar cholangiocarcinoma. Gastrointest. Endosc. 57: 860–867.PubMedCrossRefGoogle Scholar
  12. Ebata, T., Nagino, M., Kamiya, J., Uesaka, K., Nagasaka, T., and Nimura, Y., 2003. Hepatectomy with portal vein resection for hilar cholangiocar-cinoma: audit of 52 consecutive cases. Ann. Surg. 238: 720–727.PubMedCrossRefGoogle Scholar
  13. Freeman, M. L. and Overby, C., 2003. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest. Endosc. 58: 41–49.PubMedCrossRefGoogle Scholar
  14. Harewood, G. C., Baron, T. H., Rumalla, A., Wang, K. K., Gores, G. J., Stadheim, L. M., and de Groen, P. C., 2005. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholan-giocarcinoma. J. Gastroenterol. Hepatol. 20: 415–420.PubMedCrossRefGoogle Scholar
  15. Hemming, A. W., Reed, A. I., Fujita, S., Foley, D. P., and Howard, R. J., 2005. Surgical manage ment of hilar cholangiocarcinoma. Ann. Surg. 241: 693–699; discussion 699–702.PubMedCrossRefGoogle Scholar
  16. Isayama, H., Komatsu, Y., Tsujino, T., Sasahira, N., Hirano, K., Toda, N., Nakai, Y., Yamamoto, N., Tada, M., Yoshida, H., Shiratori, Y., Kawabe, T., and Omata, M., 2004. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut 53: 729–734.PubMedCrossRefGoogle Scholar
  17. Kadakia, S. C. and Starnes, E., 1992. Comparison of 10 French gauge stent with 11.5 French gauge stent in patients with biliary tract diseases. Gastrointest. Endosc. 38: 454–459.PubMedCrossRefGoogle Scholar
  18. Kawasaki, S., Imamura, H., Kobayashi, A., Noike, T., Miwa, S., and Miyagawa, S., 2003. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann. Surg. 238: 84–92.PubMedCrossRefGoogle Scholar
  19. Khan, S. A., Taylor-Robinson, S. D., Toledano, M. B., Beck, A., Elliott, P., and Thomas, H. C., 2002. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J. Hepatol. 37: 806–183.PubMedCrossRefGoogle Scholar
  20. Kondo, S., Hirano, S., Ambo, Y., Tanaka, E., Okushiba, S., Morikawa, T., and Katoh, H., 2004. Forty consecutive resections of hilar cholangio-carcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann. Surg. 240: 95–101.PubMedCrossRefGoogle Scholar
  21. Kosuge, T., Yamamoto, J., Shimada, K., Yamasaki, S., and Makuuchi, M., 1999. Improved surgical results for hilar cholangiocarcinoma with pro cedures including major hepatic resection. Ann. Surg. 230: 663–671.PubMedCrossRefGoogle Scholar
  22. Lazaridis, K. N. and Gores, G. J., 2005. Cholangiocarcinoma. Gastroenterology 128: 1655–1667.PubMedCrossRefGoogle Scholar
  23. Lillemoe, K. D., Cameron, J. L., Hardacre, J. M., Sohn, T. A., Sauter, P. K., Coleman, J., Pitt, H. A., and Yeo, C. J., 1999. Is prophylactic gastro-jejunostomy indicated for unresectable periam-pullary cancer? A prospective randomized trial. Ann. Surg. 230: 322–328; discussion 328–330.PubMedCrossRefGoogle Scholar
  24. Liu, C. L., Lo, C. M., Lai, E. C., and Fan, S. T., 1998. Endoscopic retrograde cholangiopancrea-tography and endoscopic endoprosthesis inser tion in patients with Klatskin tumors. Arch. Surg. 133: 293–296.PubMedCrossRefGoogle Scholar
  25. McCaughan, J. S., Jr., Mertens, B. F., Cho, C., Barabash, R. D., and Payton, H. W., 1991. Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report. Arch. Surg. 126: 111–113.PubMedGoogle Scholar
  26. Miyazaki, M., Ito, H., Nakagawa, K., Ambiru, S., Shimizu, H., Shimizu, Y., Kato, A., Nakamura, S., Omoto, H., Nakajima, N., Kimura, F., and Suwa, T., 1998. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery 123: 131–136.PubMedGoogle Scholar
  27. Nanashima, A., Yamaguchi, H., Shibasaki, S., Ide, N., Sawai, T., Tsuji, T., Hidaka, S., Sumida, Y., Nakagoe, T., and Nagayasu, T., 2004. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study. J. Gastroenterol. 39: 1095–1101.PubMedCrossRefGoogle Scholar
  28. Ortner, M. A., 2000. Photodynamic therapy of cholangiocarcinoma cancer. Gastrointest. Endosc. Clin. N. Am. 10: 481–486.PubMedGoogle Scholar
  29. Ortner, M. A., Liebetruth, J., Schreiber, S., Hanft, M., Wruck, U., Fusco, V., Muller, J. M., Hortnagl, H., and Lochs, H., 1998. Photodynamic ther apy of nonresectable cholangiocarcinoma. Gastroenterology 114: 536–542.PubMedCrossRefGoogle Scholar
  30. Ortner, M. E. J., Caca, K., Berr, F., Liebetruth, J., Mansmann, U., Huster, D., Voderholzer, W., Schachschal, G., Mössner, J., and Lochs, H., 2003. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a ran-domized prospective study. Gastroenterology 125: 1355–1363.PubMedCrossRefGoogle Scholar
  31. Pereira, S. P., Ayaru, L., Hatfield, A. R., Rogowska, A., and Bown, S., 2005a. Photodynamic ther apy (PDT) of malignant biliary strictures using meso-tetrahydroxyphenylchlorin (mTHPC). J. Clin. Oncol. 23: abstract 4176 (ASCO).Google Scholar
  32. Pereira, S. P., Ragunath, K., Devlin, J., and Meadows, H. M., 2005b. Preliminary results of a phase II trial to examine the safety and efficacy of por-fimer sodium photodynamic therapy (PDT) in locally advanced biliary tract carcinoma (BTC). J. Clin. Oncol. 23: abstract 4180 (ASCO).Google Scholar
  33. Polydorou, A. A., Cairns, S. R., Dowsett, J. F., Hatfield, A. R., Salmon, P. R., Cotton, P. B., and Russell, R. C., 1991. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut 32: 685–689.PubMedCrossRefGoogle Scholar
  34. Polydorou, A. A., Chisholm, E. M., Romanos, A. A., Dowsett, J. F., Cotton, P. B., Hatfield, A. R., and Russell, R. C., 1989. A comparison of right versus left hepatic duct endoprosthesis insertion in malignant hilar biliary obstruction. Endoscopy 21: 266–271.PubMedCrossRefGoogle Scholar
  35. Prasad, G., Wang, K. K., Baron, T. H., Buttar, N. S., WongKeeSong, M., Borkenhagen, L., Lutzke, L., Papanfuss, S., Gores, G., and Roberts, L., 2005. Factors predicting Survival in patients with cholan-giocarcinoma treated with photodynamic therapy. Gastroenterology: abstract T1090 (DDW).Google Scholar
  36. Prat, F., Chapat, O., Ducot, B., Ponchon, T., Pelletier, G., Fritsch, J., Choury, A. D., and Buffet, C., 1998. A randomized trial of endoscopic drain age methods for inoperable malignant strictures of the common bile duct. Gastrointest. Endosc. 47: 1–7.PubMedCrossRefGoogle Scholar
  37. Raju, G. S., Sud, R., Elfert, A. A., Enaba, M., Kalloo, A., and Pasricha, P. J., 2006. Biliary drainage by using stents without a central lumen: a pilot study. Gastrointest. Endosc. 63: 317–320.PubMedCrossRefGoogle Scholar
  38. Rumalla, A., Baron, T. H., Wang, K. K., Gores, G. J., Stadheim, L. M., and de Groen, P. C., 2001. Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest. Endosc. 53: 500–504.PubMedCrossRefGoogle Scholar
  39. Schiefke, I., Zabel-Langhennig, A., Wiedmann, M., Huster, D., Witzigmann, H., Mossner, J., Berr, F., and Caca, K., 2003. Self-expandable metallic stents for malignant duodenal obstruc tion caused by biliary tract cancer. Gastrointest. Endosc. 58: 213–219.PubMedCrossRefGoogle Scholar
  40. Seyama, Y., Kubota, K., Sano, K., Noie, T., Takayama, T., Kosuge, T., and Makuuchi, M., 2003. Long-term outcome of extended hemi-hepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann. Surg. 238: 73–83.PubMedCrossRefGoogle Scholar
  41. Shim, C. S., Cheon, Y. K., Cha, S. W., Bhandari, S., Moon, J. H., Cho, Y. D., Kim, Y. S., Lee, L. S., Lee, M. S., and Kim, B. S., 2005. Prospective study of the effectiveness of percutaneous tran-shepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultra-sonography in response assessment. Endoscopy 37: 425–433.PubMedCrossRefGoogle Scholar
  42. Soderlund, C. and Linder, S., 2006. Covered metal versus plastic stents for malignant com mon bile duct stenosis: a prospective, rand omized, controlled trial. Gastrointest. Endosc. 63: 986–995.PubMedCrossRefGoogle Scholar
  43. Speer, A. G., Cotton, P. B. and MacRae, K. D., 1988. Endoscopic management of malignant biliary obstruction: stents of 10 French gauge are preferable to stents of 8 French gauge. Gastrointest. Endosc. 34: 412–417.PubMedCrossRefGoogle Scholar
  44. Speer, A. G., Cotton, P. B., Russell, R. C., Mason, R. R., Hatfield, A. R., Leung, J. W., MacRae, K. D., Houghton, J., and Lennon, C. A., 1987. Randomised trial of endoscopic versus percu taneous stent insertion in malignant obstructive jaundice. Lancet 2: 57–62.PubMedCrossRefGoogle Scholar
  45. Todoroki, T., Kawamoto, T., Koike, N., Takahashi, H., Yoshida, S., Kashiwagi, H., Takada, Y., Otsuka, M., and Fukao, K., 2000. Radical resec tion of hilar bile duct carcinoma and predictors of survival. Br. J. Surg. 87: 306–313.PubMedCrossRefGoogle Scholar
  46. Tringali, A., Mutignani, M., Perri, V., Zuccala, G., Cipolletta, L., Bianco, M. A., Rotondano, G., Philipper, M., Schumacher, B., Neuhaus, H., Schmit, A., Deviere, J., and Costamagna, G., 2003. A prospective, randomized multicenter trial comparing DoubleLayer and polyethylene stents for malignant distal common bile duct strictures. Endoscopy 35: 992–997.PubMedCrossRefGoogle Scholar
  47. van Berkel, A. M., Boland, C., Redekop, W. K., Bergman, J. J., Groen, A. K., Tytgat, G. N., and Huibregtse, K., 1998. A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction. Endoscopy 30: 681–686.PubMedCrossRefGoogle Scholar
  48. Wagner, H. J., Knyrim, K., Vakil, N., and Klose, K. J., 1993. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and ran domized trial. Endoscopy 25: 213–218.PubMedCrossRefGoogle Scholar
  49. Welzel, T. M., McGlynn, K. A., Hsing, A. W., O'Brien, T. R., and Pfeiffer, R. M., 2006. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J. Natl. Cancer Inst. 98: 873–875.PubMedCrossRefGoogle Scholar
  50. West, J., Wood, H., Logan, R. F., Quinn, M., and Aithal, G. P., 2006. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001. Br. J. Cancer. 94: 1751–1758.PubMedCrossRefGoogle Scholar
  51. Wiedmann, M., Berr, F., Schiefke, I., Witzigmann, H., Kohlhaw, K., Mossner, J., and Caca, K., 2004a. Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study. Gastrointest. Endosc. 60: 68–75.CrossRefGoogle Scholar
  52. Wiedmann, M., Caca, K., Berr, F., Schiefke, I., Tannapfel, A., Wittekind, C., Mossner, J., Hauss, J., and Witzigmann, H., 2003. Neoadjuvant pho-todynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Cancer 97: 2783–2790.PubMedCrossRefGoogle Scholar
  53. Wiedmann, M., Dietrich, A., Mossner, J., Witzigmann, H., and Caca, K., 2004b. Combined percutaneous transhepatic biliary drainage with port implantation for management of patients with malignant biliary obstruction. Gastrointest. Endosc. 60: 117–120.CrossRefGoogle Scholar
  54. Witzigmann, H., Berr, F., Ringel, U., Caca, K., Uhlmann, D., Schoppmeyer, K., Tannapfel, A., Wittekind, C., Mossner, J., Hauss, J., and Wiedmann, M., 2006. Surgical and Palliative Management and Outcome in 184 Patients With Hilar Cholangiocarcinoma: Palliative Photodynamic Therapy Plus Stenting is Comparable to R1/R2 Resection. Ann. Surg. 244: 230–239.PubMedCrossRefGoogle Scholar
  55. Yoon, W. J., Lee, J. K., Lee, K. H., Lee, W. J., Ryu, J. K., Kim, Y. T., and Yoon, Y. B., 2006. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest. Endosc. 63: 996–1000.PubMedCrossRefGoogle Scholar
  56. Zoepf, T., Jakobs, R., Arnold, J. C., Apel, D., and Riemann, J. F., 2005. Palliation of nonresectable bile duct cancer: improved survival after pho-todynamic therapy. Am. J. Gastroenterol. 100: 2426–2430.PubMedCrossRefGoogle Scholar
  57. Zoepf, T., Jakobs, R., Arnold, J. C., Apel, D., Rosenbaum, A., and Riemann, J. F., 2001a. Photodynamic therapy for palliation of nonresect-able bile duct cancer — preliminary results with a new diode laser system. Am. J. Gastroenterol. 96: 2093–2097.Google Scholar
  58. Zoepf, T., Jakobs, R., Rosenbaum, A., Apel, D., Arnold, J. C., and Riemann, J. F., 2001b. Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer. Gastrointest. Endosc. 54: 763–766.CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media B.V. 2009

Authors and Affiliations

  • Marcus Wiedmann
    • 1
  • Joachim Mössner
    • 1
  • Helmut Witzigmann
    • 1
  1. 1.Department of Internal Medicine IIUniversity of LeipzigLeipzigGermany

Personalised recommendations